Natural Compounds Endowed with Cholinergic or Anticholinergic Activity. Enhancement of Acetylcholine Release by a Quaternary Derivative of l-Hyoscyamine
Tóm tắt
New compounds that target nicotinic receptors (nAChRs) have been sought to correct disorders affecting cholinergic transmission in central and peripheral synapses. A quaternary derivate of l-hyoscyamine, phenthonium (Phen), was shown by our group to enhance the spontaneous acetylcholine (ACh) release without altering the nerve-induced transmitter release at the neuromuscular junction. The effect was unrelated to membrane depolarization, and was not induced by an increase of calcium influx into the nerve terminal. Phen also presented a competitive antimuscarinic activity and blocked noncompetitively the neuromuscular transmission. In this work we re-examined the mechanisms underlying the facilitatory actions of Phen on [3H]-ACh release in isolated ganglia of the guinea pig ileal myenteric plexus. Exposure of the preparations to Phen (10-50 μM) increased the release of [3H]-ACh by 81 to 68% over the basal. The effect was not affected by the ganglionic nAChR antagonist hexamethonium (1 nM) at a concentration that inhibited the increase of [3H]-ACh release induced by the nicotinic agonist dimethylphenylpiperazinium (DMPP, 30 μM). Association of Phen (10 μM) with DMPP potentiated the facilitatory effect of Phen. [3H]-ACh release was not altered by the muscarinic antagonists atropine (1 nM) or pirenzepine (1 μM). However, both antagonists inhibited the release of [3H]-ACh induced by either the muscarinic M1 agonist McN-343 (10 μM) or Phen (20 μM). The facilitatory effect of Phen was not altered by CdCl2 (50 mM), but it was potentiated in the presence of tetraethylammonium (40 mM). The results indicate that the facilitatory action of Phen appears to be mediated by an increase of the inwardly rectifying potassium channels conductance probably related to the compound antimuscarinic activity.
Từ khóa
Tài liệu tham khảo
Albuquerque, E. X., Pereira, E. F., Alkondon, M., & Rogers, S. W. (2009). Mammalian nicotinic acetylcholine receptors: From structure to function. Physiological Reviews, 89(1), 73–120.
Birks, J. (2006). Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD005593. doi:10.1002/14651858.CD005593.
Bowman, W. C., Marshall, I. G., Gibb, A. J., & Harborne, A. J. (1988). Feedback control of transmitter release at the neuromuscular junction. Trends in Pharmacological Sciences, 9, 16–20.
Fann, M. L., Souccar, C., & Lapa, A. J. (1990). Phenthonium, a quaternary derivate of (-) hyoscyamine, enhances the spontaneous release of acetylcholine at the rat motor nerve terminals. British Journal of Pharmacology, 100, 441–446.
Galligan, J. J. (2002). Pharmacology of synaptic transmission in the enteric nervous system. Current Opinion in Pharmacology, 2, 623–629.
Giacobini, E. (2000). Cholinesterase inhibitors: From the Calabar bean to Alzheimer therapy. In E. Giacobini (Ed.), Cholinesterases and cholinesterase inhibitors (pp. 181–226). London: Martin Dunitz.
Gutman, G. A., & Chandy, K. G. (2002). Potassium channels. In W. A. Caterall, K. G. Chandy & G. A. Gutman (Eds.), The IUPHAR compendium of voltage-gated ion channels. UK: Nightingale Press.
Kilbinger, H., & Nafziger, M. (1985). Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexus. Naunyn-Schmiedebergs Archives of Pharmacology, 328, 304–309.
Lima-Landman, M. T. R., Munhoz, E., Souccar, C., De Lima, T. C. M., & Lapa, A. J. (2008). Phenthonium [N-(4-phenyl) phenacyl l-hyoscyamine] effects on alfa 3 beta 4 nicotinic receptors at the rat vas deferens sympathetic nerve endings. XIII International Symposium on Cholinergic Mechanisms (p. 60). Brazil: Foz do Iguaçu.
Maelicke, A., & Albuquerque, E. X. (2000). Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer´s disease. European Journal of Pharmacology, 393, 165–170.
Mandl, P., & Kiss, J. P. (2007). Role of presynaptic nicotinic acetylcholine receptors in the regulation of gastrointestinal motility. Brain Research Bulletin, 72, 194–200.
Paterson, D., & Nordberg, A. (2000). Neuronal nicotinic receptors in the human brain. Progress in Neurobiology, 61(1), 75–111.
Souccar, C., Soldera, J. C., Cysneiros, R. M., Gonçalo, M. C., & Lapa, A. J. (1994). Prejunctional effect of the quaternary derivatives of l-hyoscyamine at the rat neuromuscular junction. A structure-activity relationship study. General Pharmacology, 25, 1397–1404.
Souccar, C., Lima-Landman, M. T. R., Ballejo, G., & Lapa, A. J. (1998). Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivate of (-) hyoscyamine, in skeletal muscles. British Journal of Pharmacology, 124, 1270–1276.
Starke, K., Göthert, M., & Kilbinger, H. (1989). Modulation of neurotransmitter release by presynaptic autoreceptors. Physiological Reviews, 69, 864–989.
Summer, W. K., Viesselman, J. O., Marsh, G. M., & Candelora, K. (1981). Use of THA in the treatment of Alzheimer-like dementia: Pilot study in twelve patrons. Biological Psychiatry, 16, 145–153.
Surprenant, A. (1994). Control of the gastrointestinal tract by enteric neurons. Annual Review of Physiology, 56, 117–140.
Takahashi, T., Tsunoda, Y., Lu, Y., Wiley, J., & Owyang, C. (1992). Nicotinic receptor-evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels. Journal of Pharmacology and Experimental Therapeutics, 263, 1–5.